Skip to main content

Solid Biosciences Inc.

SLDB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001707502

No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Solid Biosciences Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of SLDB: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders10492−12
Shares79.1M80.2M+1.06M (+1.3%)
Value$437.6M$293.4M−$144.2M (−33.0%)

New holders (13)

Institutions that held Solid Biosciences Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to SLDB in Q2 2021
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC384,785$1.41M0.00%
QS Investors, LLC76,200$279.0K0.00%
Assenagon Asset Management S.A.42,600$156.0K0.00%
Principal Financial Group Inc25,426$93.0K0.00%
Acadian Asset Management LLC21,921$80.0K0.00%
Invesco Ltd.20,051$73.0K0.00%
Jump Financial, LLC17,824$65.0K0.01%
ProShare Advisors LLC15,469$57.0K0.00%
Windsor Creek Advisors, LLC15,000$55.0K0.02%
Victory Capital Management Inc12,861$47.0K0.00%
XTX Topco Ltd12,759$47.0K0.02%
Corsicana & Co.4,090$15.0K0.01%
Signaturefd, LLC433$2.00K0.00%

Sold out (25)

Institutions that held Solid Biosciences Inc. at the end of Q1 2021 and filed for Q2 2021 without it.